| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $11,559 | $12,642 | $13,399 | $14,282 | $15,828 |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $1,358 | $1,363 | $1,004 | $1,175 | $1,682 |
| Net Income | $944 | $992 | $676 | $718 | $1,142 |

Edwyn
| Metric | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | $11,559 | $12,642 | $13,399 | $14,282 | $15,828 |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $1,358 | $1,363 | $1,004 | $1,175 | $1,682 |
| Net Income | $944 | $992 | $676 | $718 | $1,142 |
Over the past five years, UNIVERSAL HEALTH SERVICES, INC. has demonstrated steady revenue growth, increasing from approximately USD 11.56 billion in 2020 to nearly USD 15.83 billion in 2024. This consistent rise—around 10% on average year over year—suggests robust topline performance in an industry characterized by demographic trends and increasing demand for healthcare services. However, while revenues have grown, the gross profit line remains consistently reported as zero, indicating that either gross profit was not separately disclosed or that different accounting treatment was applied, which limits our insight into cost of goods sold and direct margins. In contrast, operating and net incomes have experienced notable volatility over the review period. Operating income fell from USD 1.36 billion in 2021 to about USD 1.00 billion in 2022—a decline of roughly 26%—before recovering to USD 1.68 billion in 2024, marking a significant rebound of nearly 43% from 2023 levels. Net income exhibited a similar pattern, declining from near USD 992 million in 2021 to about USD 676 million in 2022 (roughly a 32% drop) and then improving to USD 1.14 billion in 2024. These swings, particularly the pronounced dip in 2022 followed by a robust recovery, may reflect underlying operational challenges such as cost pressures, changes in service mix, or shifts in reimbursement dynamics within the healthcare sector. Overall, despite the temporary setbacks in profitability metrics, the company appears to maintain strong revenue generation and operational resilience, suggesting an ability to adjust to market conditions and sustain long-term financial health.
This analysis is for informational purposes only and does not constitute financial advice or recommendations for any investment decisions. Please consult with a qualified financial professional for personalized guidance.